Law360, New York (October 09, 2009, 2:34 PM ET) -- In a dispute over whether the agreement was unfair, a federal appeals court is considering whether to reject a $24 million settlement in a suit brought by consumers against AstraZeneca Pharmaceuticals LP over alleged gross inflating of prices for prostate cancer drug Zoladex.
The U.S. Court of Appeals for the First Circuit heard arguments Thursday over plaintiff M. Joyce Howe's challenge to the settlement, in which she and her attorney Donald E. Haviland argued that the settlement was improperly negotiated, includes too many purported class members,...
1st Circ. Considers Rejecting $24M Zoladex Deal
To view the full article, take a free trial now.
